Aptadir

CE-Ventures has led a €40 million seed round for Aptadir Therapeutics, described as one of the largest seed investments in European biotech. The funding will support the early-stage therapeutics company as it advances its pipeline. The size of the round at seed stage stands out in a market where biotech funding has become more selective, drawing attention from investors and industry watchers.